Sutro Biopharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $8,520 | $25,706 | $13,008 | $113,721 |
Gross Profit | 8,520 | -36,314 | 11,247 | 111,990 |
EBITDA | -39,078 | -38,934 | -49,268 | 44,883 |
EBIT | -40,877 | -40,724 | -51,029 | 43,152 |
Net Income | -48,787 | -48,018 | -58,213 | 31,065 |
Net Change In Cash | 8,520 | 25,706 | 13,008 | 113,721 |
Free Cash Flow | -65,344 | 8,699 | -65,187 | 12,631 |
Cash | 174,579 | 90,788 | 65,218 | 69,268 |
Basic Shares | 82,043 | 81,224 | 61,457 | 61,009 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $153,731 | $67,772 | $61,880 | $42,722 |
Gross Profit | 146,915 | 59,484 | 52,107 | -34,239 |
EBITDA | -67,915 | -105,070 | -98,524 | -23,754 |
EBIT | -74,731 | -113,358 | -108,297 | -28,051 |
Net Income | -106,793 | -119,204 | -108,675 | -36,205 |
Net Change In Cash | 153,731 | 67,772 | 61,880 | 42,722 |
Cost of Revenue | -175,738 | 202,049 | ||
Free Cash Flow | -115,931 | -4,309 | -97,002 | -74,931 |
Cash | 69,268 | 47,254 | 30,414 | 206,152 |
Basic Shares | 60,163 | 50,739 | 46,119 | 32,573 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.49 |
2024-06-30 | -$0.59 |
2024-03-31 | -$0.95 |
2023-12-31 | $0.52 |
